Search Within
Document Type
1245-13-2
Applied Filters:
Keyword:'1245-13-2'
Showing 1-17 of 17 results for "1245-13-2" within Technical Documents
TB070VM pET-24a-d(+) Vector Map
BstEII 1 1245
BstXI 3 866 995 1118
BstYI 9 132 198 342 628 1840
2357 3806 3817 4616
Cac8I 40
CjeI 26
CjePI 20
ClaI 1 4058
CviJI 83
CviRI 22
DdeI 11
DpnI 21
DraIII 1 5068
DrdI 3 2858 3273 5023
DrdII 2 787
TB036VM pET-21a-d(+) Vector Map
SgrAI 1 383
SphI 1 539
SspI 2 4862 4993
StyI 1 57
TaqI 13
TaqII 9 972 1190 1863 3067 4406
4591 4744 4761 5105
TfiI 5 1743 2045 2215 2719 3140
ThaI 35
TseI 26
Tsp45I 8 1245 2073 2604 2817 2912
4314
Data Sheet
tyrosine kinase oncogene.2
2
Short Tandem Repeat
M18-3: 17 M15-3: 20.3
M4-2: 19.3 M6-4: 16, 17, 18
M6-7: 11, 12 M11-2:15
DataSheet - P3752
Vincent, J.B. et al., Trends Biochem. Sci., 17(3),
105-110 (1992).
2. Olczak, M. et al., Acta Biochim. Pol., 50(4),
1245-1256 (2003).
3. Kruzel, M., and Morawiecka, B., Acta Biochim.
Pol.
Quality Control Ranges: MILLIPLEX® MAP Human Cytokine/ Chemokine Magnetic Bead Panel
mL
Control 2 600 – 1245 pg/mL Control 2 535 – 1112 pg/mL
GM-CSF Control 1 91 – 188 pg/mL
TB162VM pET-30 Ek/LIC Vector Map
BsmI 2 4380 4457
BsmAI 6 890 1295 1421 1808 2935
4512
BsmBI 3 1808 2935 4512
BsmFI 4 654 2195 2565 5412
BsoFI 43
Bsp24I 10 483 515 1034 1066 1336
1368 3787 3819 3965 3997
Bsp1286I 13
BspEI 2 2 2483
TB430 pET-52b(+) Vector Map
796 1201 1327 1714 2604
3730 4507
BsmBI 2 1714 2604
BsmFI 4 196 560 2234 5200
Bsp1286I 13
BspCNI 9 93 1684 2061 2223 2763
3251 3660 4085 4604
BspEI 2 2 2152
BspHI 4 497 3683 3732 3764
BsrBI 5 141
Cellvento ModiFeed Prime COMP
6. Measure final pH: Expected pH 6.7 ± 0.3
7. Measure final osmolality: Expected osmolality
1245 ± 70 mOsmol/kg
8. Immediately filter using a sterilizing-grade filter
(≤0.22 µm). Filter recommendations
Data Sheet-SCC261
kinase oncogene.2
2
Short Tandem Repeat
M18-3: 17 M15-3: 20.3
M4-2: 19.3 M6-4: 16, 17, 18
M6-7:
Data Sheet-SCC261
enzymes kits proteins/peptides siRNA/cDNA products
page 4 of 4
2. Eur J Neurosci. 1995, 7(6): 1245-1265.
TB415VM pET-47b(+) Vector Map
2255
BsaHI 6 263 517 538 652 1151
1834
BsaWI 7 2 1513 2016 2247 3264
3411 4395
BsaXI 3 331 1869 4925
BseYI 3 1593 1728 3362
BsgI 3 1045 1245 2218
BsiEI 4 245 1979 2974 3398
BsiHKAI 6 238 694
Mouse Immunoglobulin Isotyping Magnetic Bead Panel
in Assay Buffer should be used.
• To achieve a 1:25,000 dilution, dilute 5 μL of sample into 1245 μL of
ultrapure water (1:250). Immediately dilute 5 μL of the 1:250 dilution into
495 μL
Protocol- MGAMMAG-300K
diluted in Assay Buffer should be used.
• To achieve a 1:25,000 dilution, dilute 5 μL of sample into 1245 μL of ultrapure
water (1:250). Immediately dilute 5 μL of the 1:250 dilution into 495 μL
Reprint: Industrial application of impurity flocculation to streamline antibody purification processes
in the selection of primary cell culture
clarification technology. Biotechnol. Prog. 29(5), 1239–1245
(2013).
•• A case study and financial analysis were presented comparing
clarification technology
TB055 pET System Manual
J. and Dunn, J.J. (1988) J. Bacteriol. 170, 1245–53.
Grossman, T.H., Kawasaki, E.S., Punreddy, S.R., and Osburne, M.S. (1998) Gene 209, 95–103.
USA and Canada
Acta Interactive Archive Vol 51
substitution) or benzofuro[2,3-b]indolines (C-2
substitution) (Scheme 13).83
eq 1 (Ref. 69)
Mn(OTf)2 (10 mol %)
LiClO4 (1.75 equiv)
MeCN–HOAc
40 oC, 2 h
MeS MeS
Cl
Cl
MgCl2
3 equiv
XP725 Worksheet for Lot Number 071M4826
AP2 alpha P6739
1242 7 2 6 2 AP2 alpha P6739
1243 7 2 6 3 AP2 gamma NA
1244 7 2 6 4 AP2 gamma NA
1245 7 2 6 5 Rab5 R7904
1246 7 2 6 6 Rab5 R7904
1247 7 2 6 7